VahatiCor: Funding, Investors & Team (Sep 2026)
VahatiCor develops the A-FLUX Reducer System for coronary microvascular dysfunction relief.
VahatiCor has raised $23.0M across 1 funding round on record, the most recent a Series B of $23.0M announced in Nov 2025.
That round is above the $5.6M median round size for Healthcare companies tracked on FundedIQ over the last two years.
VahatiCor Company Profile and Key Stats
Latest funding round on record: Nov 2025.
VahatiCor Funding Rounds
VahatiCor Founders and Leadership Team
Contact details for the VahatiCor team: 1 of 2 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →VahatiCor Funding Compared to Other Healthcare Startups
VahatiCor's latest round of $23.0M is above the median round in Healthcare. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like VahatiCor in Healthcare and Santa Clara
Companies Similar to VahatiCor
A company dedicated to providing healthcare procurement solutions.
BC3 Technologies is a company with the heart of Baltimore at it’s roots.
Nextvisit creates clinical notes from patient conversations in under 30 seconds, helping providers focus on…
Bayou Surgical engages in restoring vision from the soiled surgical camera without disrupting the surgical…
Indomo is a clinical-stage firm that aims to improve access to quality healthcare through novel…
VisCardia is a privately-held medical device company commercializing a proprietary implantable medical…
Brook is a remote patient monitoring and health coaching platform that helps people manage their chronic…
ATDev provides assistive technology and medical device solutions.
Rapid Nexus is a wound treatment system for chronic and nonhealing wounds.
Birches Health provides therapy and support for those struggling with behavioral and process addictions.
Swab-Bot is the way to swab hard-to-reach locations, such as vessels and other large confined spaces.
The Ridge Ohio is an addiction treatment center that provides support and treatment for adults struggling…
VahatiCor Funding FAQs
What does VahatiCor do?
VahatiCor develops the A-FLUX Reducer System for coronary microvascular dysfunction relief.
How much funding has VahatiCor raised?
VahatiCor has raised $23.0M across 1 round on record. The most recent is a Series B of $23.0M announced in Nov 2025.
When did VahatiCor last raise funding?
VahatiCor's most recent funding round on record is a Series B of $23.0M, announced in Nov 2025.
Who founded VahatiCor?
FundedIQ lists Marwan Berrada Sounni (Founder) at VahatiCor.
Where is VahatiCor headquartered?
VahatiCor is based in Santa Clara, United States.
How many employees does VahatiCor have?
VahatiCor is in the 1-10 employee band.
How does VahatiCor's funding compare to other Healthcare startups?
VahatiCor's latest round of $23.0M is above the $5.6M median round size for Healthcare companies on FundedIQ across 61 tracked companies over the last two years.
About FundedIQ's VahatiCor Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for VahatiCor is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.